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Background: Biobanks have the potential to offer a venue for chronic disease biomarker discovery, which would
allow for disease early detection and for identification of carriers of a certain predictor biomarker. To assess the
general attitudes towards genetic research and participation in biobanks in the Long Island/Queens area of New
York, and what factors would predict a positive view of such research, participants from the NSLIJ hospital system
were surveyed.
Methods: Participants were recruited at six hospital centers in the NSLIJ system during the summers of 2009 and
again in 2011 (n = 1,041). Those who opted to participate were given a questionnaire containing 22 questions
assessing demographics, lifestyle and attitudes towards genetic research. These questions addressed individual
participant’s beliefs about the importance of genetic research, willingness to participate in genetic research
themselves, and their views on informed consent issues.
Results: Respondents took a generally positive view of genetic research in general, as well as their own
participation in such research. Those with reservations were most likely to cite concerns over the privacy of their
medical and genetic information. Those who were married tended to view genetic research as important, while
those in the younger age group viewed it as less important. Prior blood donation of respondents was found to be
a predictor of their approval for genetic research. Demographic factors were not found to be predictive of personal
willingness to participate in genetic research, or of approval for the opt-out approach to consent.
Conclusions: While respondents were generally inclined to approve of genetic research, and those who
disapproved did not do so based on an underlying moral objection to such research, there is a disconnect
between the belief in the importance of genetic research and the willingness of individuals to participate
themselves. This indicates a continued concern for the ways in which genetic materials are safeguarded once they
are collected. Also indicated was a general lack of understanding about the various consent processes that go
along with genetic research, which should be addressed further to ensure the successful continuation of biobanks.
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Biobanks are the repository of a large number of indivi-
duals’ biological samples, annotated with clinical and/or
genetic information. The utilization of data and samples
stored in existing biobanks has become the cornerstone
of human genome and epigenome research. The infor-
mation is utilized, for example, to understand how envir-
onmental factors can effect genome expression as it
relates to health and disease occurrence [1,2]. Biobanks
have the potential to offer a venue for chronic disease
biomarker discovery, which would allow for disease early
detection and for identification of carriers of a certain
predictor biomarker. This could eventually enable sub-
jects to undertake preventive measures to decrease their
individual disease risk [3-10].
Despite its potential benefits, genetic research is a
highly sensitive topic for investigators, the public,
patients and ethicists alike, as genetic data is encoded in
the human tissue and is potentially identifiable. Single
nucleotide polymorphisms (SNPs) and other germ-line
genetic traits are shared with siblings, as well as other
family members, and inherited from parents. An indivi-
dual’s ethnicity, geographic birthplace, as well as many
other inherited characteristics may be inferred from the
acquisition of information in a person’s SNPs [11]. This
can have implications beyond the subject’s donation to
the biobank; it may affect the individual’s family, and
even his/her racial or ethnic group affiliation [12].
An individual can be identified within the large set of
public data already existent in the published genome-
wide association study, using only small subsets of an
individual’s genome [13]. As noted by Lin et al., a unique
individual can be identified with as few as 30–80 SNPs
[14]. Although information about an individual donor is
not immediately apparent, theoretically, with consider-
able effort and economical resources, said subject could
be identified. This can be achieved through comparison
with genetic information obtained from a personal item,
or comparison to DNA from a relative [15], combined
with available information from separate databases, such
as the National Geographic’s Genographic Project, as
well as specimens collected from people serving in the
military [16] and arrested for criminal offenses [17].
While there are currently several hundred biobanks
throughout the world, storing several million samples,
many social issues have been raised surrounding the cre-
ation and maintenance of such biobanks, including our
own. Issues such as personal and societal benefits,
informed consent, enrollment of vulnerable populations,
confidentiality, privacy, benefit of sharing, intellectual
property, data access, returning results to participants,
and commercial exploitation remain critical for main-
taining the public trust and for volunteers’ continued
participation in biobanks [16].Very few studies have addressed population beliefs and
attitudes towards genetic research and biobanking. The
purpose of the current study is to understand the gen-
eral population’s attitudes towards consenting and bank-
ing of genetic material. To accomplish this aim, an
anonymous survey was conducted during the summer of
2009 and replicated in 2011 among North Shore Long
Island Health System (NSLIJHS) patients and their fam-
ilies with the aim of assessing how people and patients
feel about banking their DNA for research purposes and




After reviewing other validated surveys [18-20], a con-
densed, 22 question version was created by our research
team, with targeted multiple choice questions and several
open-ended, qualitative questions. A health literacy expert
was involved as a consultant to ensure that the questions
fit at least an 8th grade reading level. The 2009 question-
naire consisted of three sections- one that addressed beliefs
towards genetic research, one that addressed questions of
personal privacy, and one on the process of obtaining con-
sent for genetic research. The format was compatible with
the Scantron grading system (Scantron Corporation, Eagan
MN). An additional section consisting of 4 questions was
added to the 2011 questionnaire, and was aimed at asses-
sing attitudes toward returning individual research results
from genetic testing to study participants.
Survey administration
Two anonymous surveys were conducted in 2009 and in
2011 as part of the Institutional commitment to periodic-
ally monitor the interest of the population in community-
based genetic research. A questionnaire on attitudes to-
wards genetic research and banking of genetic material
was distributed to a convenience sample of subjects attend-
ing various facilities within NSLIJHS, representing the di-
verse geographic, socioeconomic and ethnic catchment
areas of the Health System. NSLIHS is a network of
15 hospitals (Figure 1) that covers the population of
Nassau, Suffolk and Queens County in Long Island,
and Richmond County (Staten Island). The following
six centers within the NSLIJHS were targeted: Center
for Advanced Medicine, New Hyde Park; Monter Cancer
Center, New Hyde Park; Franklin Hospital, Valley Stream;
North Shore Ambulatory Surgery, Manhasset; Southside
Hospital, Bay Shore; Plainview Hospital, Plainview. Pre-
liminary meetings were conducted with the Directors of
the various sites and permission was obtained to conduct
the survey in patient waiting rooms.
Recruitment was performed by trained interviewers
who approached patients and families in the NSHLIJHS
Figure 1 Map of Long Island and Staten Island with the NSLIJHS hospitals.
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an anonymous questionnaire for research purposes.
The project underwent IRB expedited approval be-
cause of the anonymous nature of the survey through
the Feinstein Institute of Medical Research at North
Shore LIJHS. Due to survey anonymity, participants
would not be able to be re-contacted for further assess-
ment of their attitude toward genetic research. In 2009,
523 people answered the questionnaire; in 2011 there
were 518 respondents, for a total population of 1,041
participants.
Statistical analysis
Data are reported as mean +/− SD and percentages.
Comparisons between means were performed using the
t-test; comparison of percentages was done using the
chi-square test. Multiple logistic regression was run to
assess the determinants of a positive response to genetic
research and participation in a biobank (Questions 1, 2,
3, and 7). For this analysis, the responses to the two sur-
veys (2009 and 2011) were pooled. Data were analyzed
using SPSS software (SPSS Inc., Chigaco ILL).
Results
The characteristics of the population included in this
survey are reported in Table 1. Overall, the two samples
were very similar in terms of demographics. Most of the
respondents were female (63.7%), married (63.6%) and in
the median 40–59 age group (46.1%). About half of the
remaining respondents were split between the younger
(18–39 years, 24.8%) and the older age group (60+ years,
29.2%). Most of the respondents were White (68.1%),
with the second largest represented ethnic group being
Black (13.4%). The remaining 18.6% was distributed
fairly equally between Hispanic (7.2%), Asian (6.3%) and
Other (5.1%), which encompassed those of multiracial,
American Native and Pacific Islander ancestry. A largemajority of respondents had some form of higher educa-
tion (79.3%), with 26.1% representing those with graduate
degrees, and 53.2% with at least some college education.
As shown in Table 2, four target questions aimed at
assessing individual perception of genetic research were
also included. Question 1 referred to the respondent’s
opinion of societal importance of genetic research,
Question 2 assessed personal approval of genetic re-
search, Question 3 addressed use of respondent’s own
genetic data for research purposes, and Question 7
addressed respondent’s attitudes towards the idea of an
“opt-out” of consent policy for inclusion in genetic
studies. The large majority (97.7%) of respondents said
“yes” or “maybe” to the idea that it is a “gift” to society
when an individual takes part in medical research. The
remaining 2.3% of participants did not find taking part
in medical research to be important gift to society
(Question 1).
Respondents were also very approving of genetic re-
search in general (Question 2), with 82.2% unequivocally
in favor of genetic research, and only .8% against such
studies. Positive responses were similarly high regarding
Question 3, although the approval of use of one’s own
genetic material was slightly lower, with a disapproval
rate of 5.7%. A large majority of those who disapproved
of their own genetic information being used in research
responded as such out of concern for the security of
their personal information (75.3%), while others were
concerned about having an extra tube of blood drawn
(14.3%), and interfering with nature through their par-
ticipation (10.3%).
Positive responses toward the use of an “opt-out” of con-
sent policy (Question 7) for inclusion in genetic research
were far lower than those regarding the research itself.
Results were pooled for clarity of analysis, with 36.7% of
respondents answering No/Maybe, as opposed to only
63.3% of respondents who answered “Yes/Probably”
Table 1 Characteristics of the respondents to the two
surveys



















Some HS 39 (3.76)
Completed HS 176 (16.9)
Some college 275 (26.4)
Bachelor degree 279 (26.80)















Major illness in 1st degree relative
Yes 608 (58.74)
No 395 (38.17)
Don’t know 32 (3.1)
Ever donated blood
Yes 556 ( 53.43)
No 399 (38.32)
Tried, but I was not accepted 86 (8.23)
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The four questions assessing attitudes towards genetic re-
search (Questions 1, 2, 3 and 7) were analyzed. The demo-
graphic factors that best explained results for the target
questions on attitudes towards genetic research were Age
and Marital Status of respondent. General attitudes to-
wards societal importance of genetic research were signifi-
cantly associated with Age and Marital status (Table 3).
Younger subjects were less likely to respond “Yes/Maybe”
to the question (Odds Ratio: 0.21; 95% CI = 0.04-0.97).
Participants who were married, however, were more
likely to view genetic research as important for public
benefit (Odds Ratio: 5.14; 95% CI = 1.18-22.35) than
subjects who were not.
When assessing general approval of genetic research
(Table 4), having donated blood in the past was a pre-
dictor of approval of genetic research (Odds Ratio: 1.83;
CI = 1.28-2.60). The individual willingness to participate
in genetic research (Table 5) was not influenced by age,
gender, race or education. No demographic factor, in-
cluding ethnicity and religion, was significantly asso-
ciated with approval of the use of the “opt-out” consent
process in genetic research (Table 6).
Discussion
In this survey the majority of the respondents were sup-
portive of genetic research, with a very small minority
being unequivocally opposed to such studies, whether
broadly or on a personal level. The respondents who did
not approve of their genetic material being used in re-
search were generally opposed based on issues pertain-
ing either to privacy of their personal information or an
unwillingness to have extra blood drawn. Very few were
opposed on moral grounds, indicating that a large ma-
jority of participants who answered negatively about par-
ticipating in research do not have an underlying
disapproval for this type of research.
Previous research done by the U.S Department of
Human Services and the US Department of Labor
revealed 63% of responders would not participate in gen-
etic studies due to fear of workplace or insurance dis-
crimination caused by genetic conditions being revealed
through participation in genetic testing and/or research
[21]. While this federal survey was over a decade ago,
more recent studies also show a persistent fear of ad-
verse effects of utilization of genetic data, which under-
lies many Americans refusal to participate in genetic
research [20]. With the passage of the Federal Genetic
Information Non-Discrimination Act of 2008, which dis-
allows the request or usage of genetic information in any
detrimental way by employers and/ or insurance provi-
ders [21], public confidence in the protection of their in-
formation has increased, but still remains a very real
deterrent. This confidence also revolves around trust in
Table 2 Distribution of responses in the two surveys
Question N =1,041 N (%)
Beliefs about Genetic Research
1. Do you feel it is an important gift to society








3. How would you feel about your genetic data being
taken from you blood sample (your identity would





4.Would you be willing to join the BioGeneBank *
Yes 556 (52.72)
Not sure 364 (34.36)
No 137 (12.94)
5. Reasons for refusal among those who answered not
sure/no:
Having an extra tube of blood drawn 66 (14.22)
Keeping information private and secure 332 (74.02)
Interfering with nature by taking part in genetic res. 49 (11.6)
6. Would you be willing to provide extra info: about
your daily habits
Yes 586 ( 56.95)
Most likely 275 (26.68)
May be 122 (11.83)
No 47 (4.54)
6a. about your family’s health
Yes 682 (66.38)
Most likely 211 ( 20.5)
May be 89 (8.66)
No 46 (4.46)
Informed consent process
7. Would you be comfortable if an “opt-out” approach
was used in the BioGene Bank?
Yes 461 (44.37)
Most likely 197 (18.96)
Maybe 166 (15.97)
No 215 (20.71)
Table 2 Distribution of responses in the two surveys
(Continued)
8a. Uncomfortable enrolling in a research without
having the study explained to#
Yes 376 (61.94)
Probably 122 (20.11)
May be 64 (10.52)
No 46 (7.43)
8b. Concerned about being enrolled in a research
without my knowledge#
Yes 459 (74.77)
Most likely 83 (13.48)
May be 39 (6.44)
No 33 (5.33)
8c. Worried that other kinds of research would be
done that I don’t approve of#
Yes 384 (62.18)
Probably 89 (14.42)
May be 76 (12.45)
No 68 (10.96)
*this question was formulated slightly differently in the 2011 questionnaire;
the statement “in the future” was added to the question.
#excluding those who answered ‘yes’.
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ing the research, which can vary greatly by region and
by population [22]. The identification of specific partici-
pant concerns may lead to future studies on the possibil-
ity of enhanced legislative safeguards on personal
medical information when participating in genetic re-
search, and of the effects this type of security may have
upon future participation.
There have been very few studies which assess the atti-
tudes towards genetic research in the United States, and
even fewer on non-selected or hospitalized populations
in the Northeast region of the country. This type of re-
search has generally been done on either special popula-
tions, such as U.S veterans, or on populations whose
demographics do not match our own, such as those
from the 2011 Vanderbilt University study, which was
based out of Nashville, Tennessee [23]. Studies which
have been done in the northeast have concentrated more
on ethical questions pertaining to privacy of genetic in-
formation, such as that undertaken by researchers at
Johns Hopkins University [24].Outside of the U.S, sev-
eral large scale studies, such as those in Scotland [18],
Ireland [19] Canada [25], have been undertaken to assess
different population attitudes towards genetic research
and biobanking; however, differences in legislative, social
and demographic factors, make it difficult to extrapolate
the results to the Northeastern U.S.
Divergent from many previous studies was the fact
that demographic factors, including race and gender,
Table 5 Predictors of respondent’s willingness to
personally participate in genetic research (multivariate
analysis)
Variable Odds of responding




Age (years) 18-39 0.75 0.30-1.85
40-59 0.76 0.38-1.50
60+ Ref
Gender Male vs. Female 0.84 0.45-1.58
Ethnicity White vs. Other 1.04 0.53-2.06
Education Level ≤ HS Diploma 0.52 0.22-1.24
≤ College Diploma 0.58 0.30-1.12
Graduate Degree Ref




Being a parent Yes vs. No 0.65 0.27-1.58
Major Illness in 1st
Degree Relative
Yes vs. No/I don’t
know
0.92 0.49-1.71
Blood Donation Yes/Tried vs. No 0.98 0.38-2.66
Religion Yes vs. No 0.89 0.39-1.58
Table 3 Predictors of respondent’s belief in societal
importance of genetic research (multivariate regression
analysis)
Variable Odds of responding




Age(years) 18-39 0.21 0.04-0.97
40-59 0.38 0.10-1.42
60+ Ref
Gender Male vs. Female 1.44 0.57-3.62
Ethnicity White vs. Other 1.23 0.43-3.53
Education Level ≤ HS Diploma 0.75 0.23-2.45
≤ College Diploma 1.94 0.67-5.53
Graduate Degree Ref




Being a parent Yes vs. No 0.96 0.24-3.77





Blood Donation Yes/Tried vs. No 0.80 0.32-2.01
Religion Yes vs. No 1.47 0.43-4.03
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etic research. In this large geographic area, encompass-
ing Queens, Nassau and Suffolk counties, ethnicity of
the respondent was not predictive of attitudes toward
genetic research. It is interesting that despite the na-
tional debate surrounding genetic research, which isTable 4 Predictors of respondent’s approval of genetic
research (multivariate regression analysis)






Age (years) 18-39 1.09 0.63-1.89
40-59 1.10 0.71-1.70
60+ Ref
Gender Male vs. Female 1.00 0.69-1.46
Ethnicity White vs. Other 1.33 0.90-1.97
Education Level ≤ HS Diploma 0.92 0.55-1.53
≤ College Diploma 0.87 0.57-1.33
Graduate Degree Ref




Being a parent Yes vs. No 1.20 0.74-1.94
Major Illness in 1st
Degree Relative
Yes vs. No/I don’t
know
1.12 0.78-1.60
Blood Donation Yes/Tried vs. No 1.83 1.28-2.60
Religion Yes vs. No 0.91 0.64-2.86highly influenced by religious interest groups, the major-
ity of our respondents did not have any such moral ob-
jection; instead, most were not opposed to the research
in general, only to its possible personal consequences.
The questionnaire responses indicate that nearly all par-
ticipants, with the exception of a combined 6.6% fromTable 6 Predictors of respondent’s attitudes towards opt-
out consent (multivariate analysis)
Variable Odds of answering




Age (years) 18-39 0.68 0.44-1.05
40-59 0.75 0.53-1.05
60+ Ref
Gender Male vs. Female 0.86 0.64-1.15
Ethnicity White vs. Other 1.02 0.74-1.41
Education Level ≤ HS Diploma 1.03 0.69-1.54
≤ College Diploma 1.27 0.92-1.74
Graduate Degree Ref




Being a parent Yes vs. No 1.05 0.71-1.54





Blood Donation Yes/Tried vs. No 0.79 0.60-1.05
Religion Yes vs. No 0.78 0.62-1.53
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ligious group, yet a very small percentage disagreed with
genetic research on moral/religious grounds.
This indicates that perhaps the political and/or social
composition of the Queens/Long Island area has an ef-
fect which overrides most of the religious objections
which are more prevalent in other geographic areas. In
many other studies done throughout the United States,
racial identity is often a strong predictor of willingness
to participate in a research study, with minorities being
sometimes less willing to participate due to historical
abuses of their participation in such research [26]. In a
2006 study conducted in the Southern United States it
was shown that African Americans were more than 20%
less likely to enroll in a genetic study [26]. However, this
was not the case in our study, where belonging to a spe-
cific racial category did not prove predictive of approval
for, or willingness to participate in, genetic studies. It is
likely that our results are reflective of the reality and
beliefs of the most recent years, when education pro-
grams on clinical trials launched among minority and
underserved communities have continued to shed light
on the importance of research in general.
Another important issue highlighted by this survey
dealt with the concerns that survey respondents had
regarding the use of an “opt-out policy” in obtaining
informed consent. In such a policy, patients admitted or
treated in any of the NSLIJHS hospitals would be auto-
matically enrolled in the BioGene Bank research study
unless they sign a waiver stating that they would like to
be excluded. This policy is being utilized increasingly
across the country in order to ensure that genetic re-
search programs can continue to enroll subjects and
contribute to potentially groundbreaking new studies
[27]. Part of the controversy surrounding genetic re-
search in general is the way in which information is
obtained, and our results mirror this, with only 44.4%
responding that they would definitely be satisfied with
the “opt-out” approach for obtaining consent, and 20.7%
definitely opposed to the idea of this method. In
addition, over 80% of those who responded to this ques-
tion were uncomfortable with a study being done with-
out a specific explanation, and without their knowledge.
The present analysis showed that none of the demo-
graphic factors influences approval for the “opt out” of
consent policy, and that the issue should be explored
further. Yet when analyzing the qualitative responses fol-
lowing this question, it was clear that the “opt out” con-
cept was not clear to the participants, and this may
explain the participants’ conflicting responses regarding
this topic. Appropriate programs aimed at clarifying
what the options are when the “opt out” of consent pol-
icy is in place may be necessary in these populations
found to be more likely to disapprove of this policy.While bio-repositories have been in existence for sev-
eral decades, there is still a paucity of literature on the
subject of the “opt-out” consent method, and how its
utilization could potentially affect individual participa-
tion in such repositories. Approval of such a method is
often relatively low, and is also often misunderstood.
Results of such studies are often ambiguous in regards
to one another, and often have an element of confusion
as to participant understanding of certain consent pol-
icies. One such study, done at Vanderbilt University,
shows this confusion, as 85.6% approved of biobanking
genetic samples using the opt-out method, but at the
same time held the belief that written permission should
be obtained in order for DNA samples to be included
[23]. Results were far lower, but perhaps better under-
stood, in another 2011 study, in which 67% of survey
respondents favored an opt-in, rather than an opt-out
consent approach [28]. Similarly, in another survey con-
ducted at five sites throughout the United States, it was
shown that 42% of participants (n = 8,735) preferred that
consent be obtained for each new research study that an
individual’s DNA is used for, thus precluding the use of
an opt-out policy [29]. Results in 2006 Finnish and
Swedish studies were similar, with 30% of participants
(n = 1,195), and 46% of participants (n = 926), respect-
ively, preferring to have consent obtained with each
new research study involving their genetic material
[20,30]. However, it remains unclear how much individ-
ual participants understand the differing processes of
consent, and therefore, if the data collected on approval/
disapproval of opt-out is an accurate representation of
participant’s attitudes towards it.
In the 2011 survey, a question about the possibility of
receiving back the individual results of the genetic test-
ing was added: 62.3% of the participants answered they
would like to receive individual research results and only
4% said that they do not want to receive individual
results. Yet again, the concept of “returning individual
research results” was not very clear to participants; it
was clear from the open ended responses that partici-
pants put enormous expectations into any test that
relates to their genetic material, even when the study is
strictly experimental and no clinical importance is
attached to a result deriving from such study.
The return of individual research results (IRRs) is
another issue that is prevalent in ethical debates sur-
rounding biobanking, and genetic research in general.
While some feel that it is a moral obligation on the
part of researchers to disclose IRRs to participants,
others feel that the focus of such genetic research
should be on a population or societal level, and not
on an individual level [29]. While the debate con-
tinues amongst ethicists, researchers and administra-
tors, several studies have been carried out to assess
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our results is the fact that in the majority of these
studies, participants were very eager to receive IRRs,
although the preference as to the content of these
IRRs is somewhat disparate. This disparity can be
attributed to personal preference, but also to the
groups participating in these studies. For example, one
study conducted among parents of children with gen-
etic or developmental disorders saw a unanimous de-
sire to have all aspects of their children’s IRRs returned
to them, whether actionable or not [31]. This group
did, however, recognize that there should be an oppor-
tunity for parents, and participants, to choose which
results should be disclosed to them. In another study
conducted among focus groups across the United
States, the great majority of participants would want all
genetic results returned to them, while markedly less
wanted results on conditions that could not currently
be treated [29]. In several of the focus groups, partici-
pants made it known that they would not want results
that were not at all actionable, marking a divergence
from those who are living with those with genetic and/
or developmental issues already. Overall, results that
could not be interpreted or offered little insight into
specific conditions were not highly valued.
This study has several limitations: the study sample
may not be representative of certain aspects of the na-
tional demographic data since the last census; for ex-
ample, the percentage of respondents of Hispanic
ancestry, is 7.2%, which is far below the national average
of 16.3% [32].
Another limitation is the voluntary participation of the
subjects surveyed; the convenience sample may not ne-
cessarily be representative of the population living in
Long Island/Queens/Staten Island.
Conclusions
Despite these limitations, this is the first study of this
kind conducted in the greater New York area, contrib-
uting the first results on individual responses to the
utility of biobanks as sources of biologic material from
the general population. While respondents were gener-
ally inclined to approve of genetic research, and those
who disapproved did not do so based on an under-
lying moral objection to such research, there is a dis-
connect between the belief in the importance of
genetic research and the willingness of individuals to
participate themselves. This indicates a continued con-
cern for the ways in which genetic materials are safe-
guarded once they are collected. Also indicated was a
general lack of understanding about the various con-
sent processes that go along with genetic research,
which should be addressed further to ensure the suc-
cessful continuation of biobanks.Competing interests
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